The potential role of thrombopoietin in idiopathic thrombocytopenic purpura

A. von dem Borne, C. Folman, S. van den Oudenrijn, G. Linthorst, S. de Jong, M. de Haas

Research output: Contribution to journalReview articleAcademicpeer-review

15 Citations (Scopus)

Abstract

Thrombopoietin (TPO) plays a central role in the pathogenesis of idiopathic thrombocytopenic purpura (ITP), as it does in other immune-mediated thrombocytopenias. Because TPO is bound and internalized by platelets, it is destroyed together with platelets at an accelerated rate in the macrophage system. Because the spleen acts as a TPO sink, compensation of the decreased platelet count by an increased production in the bone marrow is insufficient. This aspect of ITP, as well as the use of TPO in the treatment of ITP, will be the focus of this article. (C) 2002, Elsevier Science Ltd. All rights reserved
Original languageEnglish
Pages (from-to)57-59
JournalBlood Reviews
Volume16
Issue number1
DOIs
Publication statusPublished - 2002

Cite this